P3 Research Compound
Tirzepatide 30MG
$120
30MGListed identity: dual GIP / GLP-1 receptor agonist.
Research overview
Synthetic peptide used in laboratory research involving dual incretin-receptor signaling. Research commonly examines receptor activation, downstream signaling, pathway crosstalk, and metabolic-signaling biology.
Research targets
GIP receptor · GLP-1 receptor
Research status
Commercially available medicines containing tirzepatide are FDA-approved for specific human indications, but this P3 listing is presented only as research material.
Lot documentation
Any documentation should be matched to the exact lot supplied. No testing claim is implied without lot-specific supporting documentation.
RESEARCH USE ONLY. Not for human consumption or medical use. No dosing, reconstitution, injection, administration, treatment, or human-use guidance is provided.